BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 237 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $235,764 | +0.6% | 33,300 | 0.0% | 0.00% | – |
Q2 2023 | $234,432 | +25.5% | 33,300 | +48.7% | 0.00% | – |
Q1 2023 | $186,816 | -64.9% | 22,400 | -51.6% | 0.00% | -100.0% |
Q4 2022 | $531,524 | -29.3% | 46,300 | -22.4% | 0.00% | -50.0% |
Q3 2022 | $752,000 | -84.1% | 59,700 | -86.6% | 0.00% | -50.0% |
Q2 2022 | $4,715,000 | -5.0% | 445,675 | +46.0% | 0.00% | 0.0% |
Q1 2022 | $4,962,000 | +36.2% | 305,179 | +16.0% | 0.00% | +33.3% |
Q4 2021 | $3,642,000 | +76.4% | 263,115 | +83.1% | 0.00% | +50.0% |
Q3 2021 | $2,065,000 | +3076.9% | 143,708 | +953.8% | 0.00% | – |
Q2 2020 | $65,000 | -79.0% | 13,637 | -87.4% | 0.00% | – |
Q3 2019 | $309,000 | -69.3% | 107,890 | -59.3% | 0.00% | -100.0% |
Q2 2019 | $1,005,000 | -63.1% | 265,144 | -20.8% | 0.00% | -66.7% |
Q1 2019 | $2,725,000 | +25.3% | 334,728 | +24.2% | 0.00% | +50.0% |
Q4 2018 | $2,174,000 | +2.4% | 269,403 | -3.2% | 0.00% | 0.0% |
Q3 2018 | $2,124,000 | +60.9% | 278,418 | +20.8% | 0.00% | +100.0% |
Q2 2018 | $1,320,000 | +19.5% | 230,413 | -0.6% | 0.00% | 0.0% |
Q1 2018 | $1,105,000 | +36.4% | 231,761 | +40.5% | 0.00% | 0.0% |
Q4 2017 | $810,000 | -3.0% | 164,978 | +3.5% | 0.00% | 0.0% |
Q3 2017 | $835,000 | +27.7% | 159,364 | +35.5% | 0.00% | 0.0% |
Q2 2017 | $654,000 | -35.1% | 117,637 | -2.0% | 0.00% | 0.0% |
Q1 2017 | $1,008,000 | +308.1% | 119,978 | +453.7% | 0.00% | – |
Q3 2015 | $247,000 | – | 21,670 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |